OBN's 2012 Annual Awards Dinner Celebrates UK Bioscience Success Stories

OBN's 2012 Annual Awards Dinner Celebrates UK Bioscience Success Stories PR Newswire OXFORD, England, September 12, 2012 OXFORD, England, September 12, 2012 /PRNewswire/ -- http://www.obn.org.uk/obn_/menu.php?p=rss&rn=rssfeed&prechk_news=1 OBN's Annual Awards Dinner, last night celebrated the achievements and major success stories in biotech, medtech and diagnostics over the past year at a black tie event at The Ashmolean Museum, Oxford. The Awards sought to highlight the many achievements of the UK's bioscience sector in raising funds, executing deals and supporting innovation, as well as the addition of two new awards for 2012 to recognise the "Highest Impact Investor" and the "Best Pharma BD&L Team". The 2012 award winners were: Vertex, Best New Biotech Product Award Presented by Berkley Group For the second year running, Vertex has had a first in class chemical entity approved by the FDA and the EMEA. [TM]Kalydeco is an ion channel inhibitor designed to address one of the causes of cystic fibrosis and is the first treatment that addresses the underlying etiology of the disease. Oxtex, Best New Medtech Product Award Presented by JA Kemp Oxtex is a manufacturer of anisotropic self-inflating tissue expanders for use in reconstructive plastic surgery and restorative dentistry.